Literature DB >> 21676994

Diagnostic shifts during the decade following first admission for psychosis.

Evelyn J Bromet1, Roman Kotov, Laura J Fochtmann, Gabrielle A Carlson, Marsha Tanenberg-Karant, Camilo Ruggero, Su-wei Chang.   

Abstract

OBJECTIVE: Diagnostic shifts have been prospectively examined in the short term, but the long-term stability of diagnoses has rarely been evaluated. The authors examined diagnostic shifts over a 10-year follow-up period.
METHOD: A cohort of 470 first-admission patients with psychotic disorders was systematically assessed at baseline and at 6-month, 2-year, and 10-year follow-ups. Longitudinal best-estimate consensus diagnoses were formulated after each assessment.
RESULTS: At baseline, the diagnostic distribution was 29.6% schizophrenia spectrum disorders, 21.1% bipolar disorder with psychotic features, 17.0% major depression with psychotic features, 2.4% substance-induced psychosis, and 27.9% other psychoses. At year 10, the distribution changed to 49.8%, 24.0%, 11.1%, 7.0%, and 8.1%, respectively. Overall, diagnoses were changed for 50.7% of study participants at some point during the study. Most participants who were initially diagnosed with schizophrenia or bipolar disorder retained the diagnosis at year 10 (89.2% and 77.8%, respectively). However, 32.0% of participants (N=98) originally given a non-schizophrenia diagnosis had gradually shifted to a schizophrenia diagnosis by year 10. The second largest shift was to bipolar disorder (10.7% of those not given this diagnosis at baseline). Changes in the clinical picture explained many diagnostic shifts. In particular, poorer functioning and greater negative and psychotic symptom ratings predicted a subsequent shift to schizophrenia. Better functioning and lower negative and depressive symptom ratings predicted the shift to bipolar disorder.
CONCLUSIONS: First-admission patients with psychotic disorders run the risk of being misclassified at early stages in the illness course, including more than 2 years after first hospitalization. Diagnosis should be reassessed at all follow-up points.

Entities:  

Mesh:

Year:  2011        PMID: 21676994      PMCID: PMC3589618          DOI: 10.1176/appi.ajp.2011.11010048

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  33 in total

1.  Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis.

Authors:  J E Schwartz; S Fennig; M Tanenberg-Karant; G Carlson; T Craig; N Galambos; J Lavelle; E J Bromet
Journal:  Arch Gen Psychiatry       Date:  2000-06

2.  Missing data: our view of the state of the art.

Authors:  Joseph L Schafer; John W Graham
Journal:  Psychol Methods       Date:  2002-06

3.  Anchoring the BPRS: an aid to improved reliability.

Authors:  M G Woerner; S Mannuzza; J M Kane
Journal:  Psychopharmacol Bull       Date:  1988

4.  Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia.

Authors:  E Robins; S B Guze
Journal:  Am J Psychiatry       Date:  1970-01       Impact factor: 18.112

5.  Risk for bipolar illness in patients initially hospitalized for unipolar depression.

Authors:  J F Goldberg; M Harrow; J E Whiteside
Journal:  Am J Psychiatry       Date:  2001-08       Impact factor: 18.112

6.  Rapid versus delayed readmission in first-admission psychosis: quality indicators for managed care?

Authors:  T J Craig; S Fennig; M Tanenberg-Karant; E J Bromet
Journal:  Ann Clin Psychiatry       Date:  2000-12       Impact factor: 1.567

7.  The epidemiology of psychosis: the Suffolk County Mental Health Project.

Authors:  E J Bromet; J E Schwartz; S Fennig; L Geller; L Jandorf; B Kovasznay; J Lavelle; A Miller; C Pato; R Ram
Journal:  Schizophr Bull       Date:  1992       Impact factor: 9.306

8.  The impact of diagnostic misclassification on the pattern of familial aggregation and coaggregation of psychiatric illness.

Authors:  K S Kendler
Journal:  J Psychiatr Res       Date:  1987       Impact factor: 4.791

9.  Distinguishing between first-admission schizophreniform disorder and schizophrenia.

Authors:  Bushra Naz; Evelyn J Bromet; Ramin Mojtabai
Journal:  Schizophr Res       Date:  2003-07-01       Impact factor: 4.939

10.  Atypical antipsychotics in first admission schizophrenia: medication continuation and outcomes.

Authors:  Ramin Mojtabai; Janet Lavelle; P Joseph Gibson; Evelyn J Bromet
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

View more
  79 in total

1.  Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project.

Authors:  Roman Kotov; Laura Fochtmann; Kaiqiao Li; Marsha Tanenberg-Karant; Eduardo A Constantino; Joan Rubinstein; Greg Perlman; Eva Velthorst; Anne-Kathrin J Fett; Gabrielle Carlson; Evelyn J Bromet
Journal:  Am J Psychiatry       Date:  2017-08-04       Impact factor: 18.112

2.  Pathogenic rare copy number variants in community-based schizophrenia suggest a potential role for clinical microarrays.

Authors:  Gregory Costain; Anath C Lionel; Daniele Merico; Pamela Forsythe; Kathryn Russell; Chelsea Lowther; Tracy Yuen; Janice Husted; Dimitri J Stavropoulos; Marsha Speevak; Eva W C Chow; Christian R Marshall; Stephen W Scherer; Anne S Bassett
Journal:  Hum Mol Genet       Date:  2013-06-27       Impact factor: 6.150

3.  Clinical significance of auditory target P300 subcomponents in psychosis: Differential diagnosis, symptom profiles, and course.

Authors:  Greg Perlman; Dan Foti; Felicia Jackson; Roman Kotov; Eduardo Constantino; Greg Hajcak
Journal:  Schizophr Res       Date:  2015-04-29       Impact factor: 4.939

4.  Disconnection Between Amygdala and Medial Prefrontal Cortex in Psychotic Disorders.

Authors:  Prerona Mukherjee; Amri Sabharwal; Roman Kotov; Akos Szekely; Ramin Parsey; Deanna M Barch; Aprajita Mohanty
Journal:  Schizophr Bull       Date:  2016-02-23       Impact factor: 9.306

Review 5.  Searching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia.

Authors:  Sabina Berretta; Stephan Heckers; Francine M Benes
Journal:  Schizophr Res       Date:  2014-11-11       Impact factor: 4.939

Review 6.  Toward a comprehensive clinical staging model for bipolar disorder: integrating the evidence.

Authors:  Anne Duffy
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

Review 7.  Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naïve patients with nonaffective psychosis.

Authors:  Anne Marie Greenhalgh; Leticia Gonzalez-Blanco; Clemente Garcia-Rizo; Emilio Fernandez-Egea; Brian Miller; Miguel Bernardo Arroyo; Brian Kirkpatrick
Journal:  Schizophr Res       Date:  2016-10-17       Impact factor: 4.939

8.  McLean OnTrack: a transdiagnostic program for early intervention in first-episode psychosis.

Authors:  Ann K Shinn; Kirsten W Bolton; Rakesh Karmacharya; Kathryn E Lewandowski; Cagri Yuksel; Justin T Baker; Virginie-Anne Chouinard; Samira M Pingali; Hilary Bye; Katherine Cederbaum; Dost Öngür
Journal:  Early Interv Psychiatry       Date:  2015-11-29       Impact factor: 2.732

Review 9.  Structural and functional neuroimaging studies in major depressive disorder with psychotic features: a critical review.

Authors:  Geraldo F Busatto
Journal:  Schizophr Bull       Date:  2013-04-24       Impact factor: 9.306

10.  Epidemiological and clinical characterization following a first psychotic episode in major depressive disorder: comparisons with schizophrenia and bipolar I disorder in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).

Authors:  Olabisi Owoeye; Tara Kingston; Paul J Scully; Patrizia Baldwin; David Browne; Anthony Kinsella; Vincent Russell; Eadbhard O'Callaghan; John L Waddington
Journal:  Schizophr Bull       Date:  2013-05-28       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.